Julie Hambleton Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Julie Hambleton.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Julie Hambleton. Julie Hambleton is EVP & Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and SVP & Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in IGM Biosciences, Inc. ($IGMS) and SVP, Chief Medical Officer in IDEAYA Biosciences, Inc. ($IDYA) and Director in SpringWorks Therapeutics, Inc. ($SWTX).

Julie Hambleton in FIVE PRIME THERAPEUTICS, INC.

Trading Symbol: FPRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Hambleton: EVP & Chief Medical Officer, SVP & Chief Medical Officer
Holdings: 84,811 shares
Current Value: $3,848,723
Latest Transaction: Nov 13 2015
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Julie Hambleton in FIVE PRIME THERAPEUTICS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, FPRX, IDYA, IGMS, SWTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Option Exercise	M	11.14	12,000	133,680	38,000
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Option Exercise	M	7.26	10,000	72,600	14,390
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Sell	S	35.33	1,108	39,146	84,811	85.9 K to 84.8 K (-1.29 %)
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Sell	S	34.33	12,000	411,960	85,919	97.9 K to 85.9 K (-12.26 %)
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Buy	M	11.14	12,000	133,680	97,919	85.9 K to 97.9 K (+13.97 %)
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Sell	S	35.23	3,400	119,782	85,919	89.3 K to 85.9 K (-3.81 %)
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Sell	S	34.75	6,600	229,350	89,319	95.9 K to 89.3 K (-6.88 %)
Nov 13 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Buy	M	7.26	10,000	72,600	95,919	85.9 K to 95.9 K (+11.64 %)
Oct 30 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Buy	P	13.70	64	877	64	0 to 64
Oct 30 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Buy	P	10.75	400	4,300	1,700	1.3 K to 1.7 K (+30.77 %)
Oct 30 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Buy	P	10.10	500	5,050	1,300	800 to 1.3 K (+62.50 %)
Oct 30 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Buy	P	14.75	800	11,800	800	0 to 800
Aug 21 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	EVP & Chief Medical ...	Grant	A	0.00	75,000	0	85,740	10.7 K to 85.7 K (+698.32 %)
Aug 19 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	SVP & Chief Medical ...	Option Exercise	A	19.25	75,000	1,443,750	75,000
May 04 2015	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	SVP & Chief Medical ...	Grant	A	0.00	7,980	0	9,979	2 K to 10 K (+399.20 %)
Aug 26 2014	FPRX	FIVE PRIME THERAPE ...	Hambleton Julie	SVP & Chief Medical ...	Option Exercise	A	11.14	50,000	557,000	50,000

Page: 1